glp-1 and parkinson's A New Treatment Strategy for Disease through the Gut–Brain Axis: The Glucagon-Like Peptide-1 Receptor Pathway Glucagon-like peptide-1 medicines in neurological

Herbal preparations that affect blood glucose levels, such as ginseng, fenugreek, or bitter melon, may have additive glucose-lowering effects when combined with semaglutide, potentially increasing the risk of hypoglycemia particularly in patients receiving other antidiabetic medications

Uric acid formation, arising from purine catabolism, is chiefly orchestrated through a sequence of enzymatic reactions involving xanthine oxidase, primarily occurring in the liver and intestines [2]

Interestingly, GEP12 elicited stronger increases in the ISR (Fig

B, Biointerfaces Journal ranking: Q1 Key takeaways: This novel peptide nanocarrier effectively counteracts cellular inflammation, senescence, and apoptosis from oxidative damage, offering a green, non-toxic, and convenient antioxidant system for skin aging prevention

Studies on ligament injuries showed similar results, with treated animals recovering strength and function faster than controls